N@N

Law Office of Brodsky & Smith, LLC Announces Investigation of Amedisys, Inc. 401(k) Plan

^{Published on 2010-06-16 15:30:19 - Market Wire}
 

BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating Amedisys, Inc. (aAmedisysa or the aCompanya) (Nasdaq:AMED) investment of Plan participants and beneficiaries assets in company stock. The investigation concerns whether administrators breached their fiduciary duties and violated the Employee Retirement Income Security Act of 1974 (aERISAa) by investing assets in company stock when it was not a prudent investment for participantsa™ retirement savings.

The investigation concerns improper behavior that harmed current and former employees that invested in the 401(k) plan. Specifically, a lawsuit seeking class action status has been filed in the United States District Court for the Middle District of Louisiana on behalf of purchasers of the securities of Amedisys, Inc. The Complaint charges that Amedisys and certain of its officers and executives violated federal securities laws. Also, on May 13, 2010, The Wall Street Journal reported that the Senate Finance Committee had started an investigation into the billing and operating practices of Amedisys. On this news, Amedisys stock fell $4.48 per share.

If you held Amedisys stock in an individual account under any of the Companya™s 401(k) plans and wish to discuss the legal ramifications of the administratora™s investment in Company stock, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], or by calling toll free 877-LEGAL-90.